Kirschfink M, Petry F, Khirwadkar K, Wigand R, Kaltwasser J P, Loos M
Institute of Immunology, University of Heidelberg, Germany.
Clin Exp Immunol. 1993 Nov;94(2):267-72. doi: 10.1111/j.1365-2249.1993.tb03442.x.
A complete functional deficiency of C1q is described in a patient suffering from SLE. From reduced plasma C1 activity of the parents a hereditary trait was assumed. The defective C1q molecule was haemolytically inactive, did not bind to immune complexes, and was not recognized by the monocyte C1q receptor. C1 activity in the patient's serum could be restored by the addition of purified C1q. Analysis by gel-filtration and ultracentrifugation experiments revealed an immunoreactive molecule of about 150 kD mol. wt, corresponding to one structural subunit of the C1q macromolecule, containing two A chain-B chain dimers and a C-C chain dimer. Applying Southern blot analysis with cDNA clones encoding for the three individual chains of the C1q molecule, no restriction fragment length polymorphism was detected, ruling out possible major alterations of the genetic information.
在一名系统性红斑狼疮患者中描述了C1q的完全功能缺陷。由于父母血浆C1活性降低,推测存在遗传特征。有缺陷的C1q分子无溶血活性,不与免疫复合物结合,也不被单核细胞C1q受体识别。通过添加纯化的C1q可恢复患者血清中的C1活性。凝胶过滤和超速离心实验分析显示,存在一个约150kD分子量的免疫反应性分子,相当于C1q大分子的一个结构亚基,包含两个A链-B链二聚体和一个C-C链二聚体。应用编码C1q分子三条独立链的cDNA克隆进行Southern印迹分析,未检测到限制性片段长度多态性,排除了遗传信息可能存在的主要改变。